Phase 3 human trials of homegrown Nano Covax vaccine to begin on June 8
More than 6,000 volunteers have registered for the third phase of human trials of homegrown Nano Covax vaccine, which is scheduled to begin on June 8, according to the Military Medical University (MMU) under the Defence Ministry.
Hanoi (VNA) – More than 6,000volunteers have registered for the third phase of human trials of homegrown Nano Covax vaccine, which is scheduled to begin on June 8, according to theMilitary Medical University (MMU) under the Defence Ministry.
AMMU representative said in this phase, the vaccine, developed by VietnameseNanogen Pharmaceutical Biotechnology JSC, will be tested on around 13,000volunteers aged between 18 and 74, in many localities nationwide.
Thethird phase, also the final one, aims to evaluate the effectiveness of thevaccine and each volunteer may only receive one jab of 25 mcg.
Director of the university Prof. Dr. Do Quyet showed his confidence in thesafety of Nano Covax vaccine with the positive results obtained from theprevious two trial phases.
Navo Covax vaccine started testing on humanson December 17 last year and has completed the second phase.
The first-phase trials showedthe vaccine was safe and vaccinated volunteers had antibodies against the UKvariant (B117).
Thesecond-phase ones were conducted on 560 volunteers dividedinto four groups, with 80 people injected with a placebo and three other groupsadministered with 25mcg, 50mcg, and 75mcg doses. However, only 554 receivedsecond shots because six people withdrew from the trial.
All of the vaccinated volunteers have developed antibodiesagainst COVID-19 at different levels.
Regarding the antibody index to neutralise the virus, peopleinjected with 25mcg dose got the highest index with more than 90 percent at14 days after the second shot and 42 days since the first jabs./.
The clinical trials of Vietnamese COVID-19 vaccine candidate Nano Covax are set to enter Phase 3 this month with the optimal dosage of 25mcg, aiming to further test the safety and efficacy of the vaccine in humans before mass production begins.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Injecting Nano Covax vaccine (Photo: VNA) 
